Bio-View Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was ILS 17.47 million compared to ILS 12.5 million a year ago. Net income was ILS 1.46 million compared to net loss of ILS 0.06 million a year ago.

Basic earnings per share from continuing operations was ILS 0.011 compared to basic loss per share from continuing operations of ILS 0.003 a year ago. Diluted earnings per share from continuing operations was ILS 0.011.